novabay pharmaceuticals  wikipedia novabay pharmaceuticals from wikipedia the free encyclopedia jump to navigation search this article needs additional citations for verification please help improve this article by adding citations to reliable sources unsourced material may be challenged and removed june  learn how and when to remove this template message novabay pharmaceuticalsinc fighting superbugs type public traded as nyse mkt nby founded  founder ron najafi key people mark sieczkarek mba chairman  interim ceo tom paulson mba cfo glenn morovp sales and marketing avenova justin m hall esq senior vice president general counsel website novabaycom novabay pharmaceuticals inc is an emeryville california based clinicalstage biopharmaceutical company focused on developing novel fastacting synthetic antiinfectives compounds these compounds are designed to mimic the bodys defense system against infection the company is currently focused on products for the eye care market major products include avenova cleared by fda for lid and lash cleansing as part of a regimen for blepharitis and neutrophase used in treatment of necrotizing fasciitis contents  history  corporate governance  products  products on the market  products under development  references  external links historyedit novabay pharmaceuticals inc was founded by ron najafi an organic chemist who had previously worked for several pharmaceutical chemical and biotech companies in the us najafi became intrigued by hocl hypochlorous acid an antimicrobial substance produced by white blood cells while investigating the chemical reaction of white blood cells during oxidative burst cycle hocl and other chlorinecontaining chemicals fight invading microbes these natural substances rapidly oxidize the cell walls of bacteria and the protein coats of viruses rendering them inactive najafi started novabay pharmaceuticals in  to create a stable version of hoclcitation needed najafi chemistry nobel laureate herbert c brown and purdue university professor dale margerum recruited dr lu wang to novabay where she is now director of product development she was able to develop the stable version of pure hypochlorous acid without bleach impurities which became novabay’s first product neutrophasehypochlorous acid as a potential wound care agent part ii pdf  neutrophase® in chronic nonhealing wounds pdf  treatment of acute necrotizing fasciitis using negative pressure wound therapy and adjunctive neutrophase irrigation under the foam not in citation given and cleared by the food and drug administration in  the product successfully treats a variety of chronic nonhealing wounds without the use of standard antibiotics novabay announced two new products named cellerx™ for plastic surgery and ilid™ cleanser now avenova that was cleared by fda for lid and lash cleansing as part of a regimen for blepharitis novabay avenova has a low toxicity but kills eyelid bacteria in dry eye or blepharitis patients  corporate governanceedit as of april  update the members of the board of directors of novabay pharmaceuticals were paul e freiman xinzhou li paul li gail maderis t alex mcpherson md phd massimo radaelli phd mark sieczkarek mijia wu bob wu and xiaoyan liu henry liu productsedit products on the marketedit avenova formerly known as ilid cleanser  neutrophase  cellerx for plastic surgery products under developmentedit novabay developed a method for making a stable pure form of hypochlorous acid hocl a substance produced by the immune system as an effective first defense against microbial invaders the company calls their proprietary formulation neutrox the companys chemists also created a related family of compounds which the company calls aganocides the company is currently developing compounds with antibacterial and antiviral action potential applications include flesheating disease problems related to indwelling urinary catheters and common eye conditions compounds are also being developed for the veterinary market referencesedit  novabay avenova has a low toxicity but kills eyelid bacteria in dry eye or blepharitis patients   treatment of acute necrotizing fasciitis using negative pressure wound therapy and adjunctive neutrophase irrigation under the foam   nnff names novabays nby neutrophase its official flesheating disease wound cleanser   hypochlorous acid as a potential wound care agent part i pdf   k summary neutrophase® skin and wound cleaner otc pdf   novabay’s new advanced ilid cleanser has been cleared by the fda for cleaning removing debris and microbes from the skin around the eyes the eyelids and eyelashes eyelid and lash cleansing as part of a regimen for blepharitis  steven e f brown february   novabay pharmaceuticals makes deal for flesheating bacteria cleanser san francisco business times retrieved june     novabay pharmaceuticals and virbac enter into a collaboration and license agreement for animal health  external linksedit companies portal wwwnovabaycom wwwavenovacom wwwdoctorsavenovacom wwwneutrophasecom wwwcellerxcom novabay pharmaceuticals inc the new york times v t e pharmaceutical companies of the united states current abbott laboratories acorda therapeutics aderis pharmaceuticals advaxis alcon alexion pharmaceuticals alkermes allergan amgen avax technologies baxter international biocryst pharmaceuticals biogen bioverativ biovest biovista bristolmyers squibb century pharmaceuticals ceragenix pharmaceuticals combe incorporated cortex pharmaceuticals cytosport cytrx danco laboratories eli lilly and company elorac endo pharmaceuticals par pharmaceutical galena biopharma genvec genentech gilead sciences institute for oneworld health intercept pharmaceuticals johnson  johnson ethicon janssen biotech mcneil consumer healthcare orthomcneil pharmaceutical kinetic concepts mallinckrodt mckesson corporation melinta therapeutics formerly ribx pharmaceuticals melior discovery mentholatum merck  co mylan myriad genetics northwest biotherapeutics norwich pharma services novabay pharmaceuticals ovation pharmaceuticals perrigo pfizer hospira searle pharmaceutical product development prasco laboratories procter  gamble proteon therapeutics purdue pharma quark pharmaceuticals regeneron repros therapeutics sarepta therapeutics savage laboratories sheffield pharmaceuticals spectrum pharmaceuticals tec laboratories teva pharmaceutical industries actavis tapi tiens biotech group titan pharmaceuticals trevena inc upshersmith laboratories valeant pharmaceuticals bausch  lomb ventria bioscience vertex pharmaceuticals west pharmaceutical services former alza amylin pharmaceuticals ariad pharmaceuticals biolex bradley pharmaceuticals cancervax cephalon cotherix covance covidien cubist pharmaceuticals cutter laboratories dnaprint genomics epix pharmaceuticals forest laboratories genta imclone systems ista pharmaceuticals king pharmaceuticals kv pharmaceutical leiner health products martek biosciences corporation s e massengill company miles laboratories naurex nereus pharmaceuticals nuvelo organon international ortho pharmaceutical osi pharmaceuticals parkedavis qualitest scheringplough smith kline  french sterling drug tanox tap pharmaceutical products trubion upjohn verus pharmaceuticals vion pharmaceuticals inc viropharma wyeth zonite products corporation list of pharmaceutical companies retrieved from httpsenwikipediaorgwindexphptitlenovabaypharmaceuticalsoldid categories companies listed on nyse mktpharmaceutical companies of the united statescompanies based in emeryville californiatechnology companies based in the san francisco bay areahealth care companies based in californiahidden categories articles needing additional references from june all articles needing additional referencespages using deprecated image syntaxall articles with unsourced statementsarticles with unsourced statements from june all articles with failed verificationarticles with failed verification from june articles containing potentially dated statements from april all articles containing potentially dated statements navigation menu personal tools not logged intalkcontributionscreate accountlog in namespaces article talk variants views read edit view history more search navigation main pagecontentsfeatured contentcurrent eventsrandom articledonate to wikipediawikipedia store interaction helpabout wikipediacommunity portalrecent changescontact page tools what links hererelated changesupload filespecial pagespermanent linkpage informationwikidata itemcite this page printexport create a bookdownload as pdfprintable version languages add links this page was last edited on  june  at  text is available under the creative commons attributionsharealike license additional terms may apply by using this site you agree to the terms of use and privacy policy wikipedia® is a registered trademark of the wikimedia foundation inc a nonprofit organization privacy policy about wikipedia disclaimers contact wikipedia developers cookie statement mobile view novabay pharmaceuticals  wikipedia novabay pharmaceuticals from wikipedia the free encyclopedia jump to navigation search this article needs additional citations for verification please help improve this article by adding citations to reliable sources unsourced material may be challenged and removed june  learn how and when to remove this template message novabay pharmaceuticalsinc fighting superbugs type public traded as nyse mkt nby founded  founder ron najafi key people mark sieczkarek mba chairman  interim ceo tom paulson mba cfo glenn morovp sales and marketing avenova justin m hall esq senior vice president general counsel website novabaycom novabay pharmaceuticals inc is an emeryville california based clinicalstage biopharmaceutical company focused on developing novel fastacting synthetic antiinfectives compounds these compounds are designed to mimic the bodys defense system against infection the company is currently focused on products for the eye care market major products include avenova cleared by fda for lid and lash cleansing as part of a regimen for blepharitis and neutrophase used in treatment of necrotizing fasciitis contents  history  corporate governance  products  products on the market  products under development  references  external links historyedit novabay pharmaceuticals inc was founded by ron najafi an organic chemist who had previously worked for several pharmaceutical chemical and biotech companies in the us najafi became intrigued by hocl hypochlorous acid an antimicrobial substance produced by white blood cells while investigating the chemical reaction of white blood cells during oxidative burst cycle hocl and other chlorinecontaining chemicals fight invading microbes these natural substances rapidly oxidize the cell walls of bacteria and the protein coats of viruses rendering them inactive najafi started novabay pharmaceuticals in  to create a stable version of hoclcitation needed najafi chemistry nobel laureate herbert c brown and purdue university professor dale margerum recruited dr lu wang to novabay where she is now director of product development she was able to develop the stable version of pure hypochlorous acid without bleach impurities which became novabay’s first product neutrophasehypochlorous acid as a potential wound care agent part ii pdf  neutrophase® in chronic nonhealing wounds pdf  treatment of acute necrotizing fasciitis using negative pressure wound therapy and adjunctive neutrophase irrigation under the foam not in citation given and cleared by the food and drug administration in  the product successfully treats a variety of chronic nonhealing wounds without the use of standard antibiotics novabay announced two new products named cellerx™ for plastic surgery and ilid™ cleanser now avenova that was cleared by fda for lid and lash cleansing as part of a regimen for blepharitis novabay avenova has a low toxicity but kills eyelid bacteria in dry eye or blepharitis patients  corporate governanceedit as of april  update the members of the board of directors of novabay pharmaceuticals were paul e freiman xinzhou li paul li gail maderis t alex mcpherson md phd massimo radaelli phd mark sieczkarek mijia wu bob wu and xiaoyan liu henry liu productsedit products on the marketedit avenova formerly known as ilid cleanser  neutrophase  cellerx for plastic surgery products under developmentedit novabay developed a method for making a stable pure form of hypochlorous acid hocl a substance produced by the immune system as an effective first defense against microbial invaders the company calls their proprietary formulation neutrox the companys chemists also created a related family of compounds which the company calls aganocides the company is currently developing compounds with antibacterial and antiviral action potential applications include flesheating disease problems related to indwelling urinary catheters and common eye conditions compounds are also being developed for the veterinary market referencesedit  novabay avenova has a low toxicity but kills eyelid bacteria in dry eye or blepharitis patients   treatment of acute necrotizing fasciitis using negative pressure wound therapy and adjunctive neutrophase irrigation under the foam   nnff names novabays nby neutrophase its official flesheating disease wound cleanser   hypochlorous acid as a potential wound care agent part i pdf   k summary neutrophase® skin and wound cleaner otc pdf   novabay’s new advanced ilid cleanser has been cleared by the fda for cleaning removing debris and microbes from the skin around the eyes the eyelids and eyelashes eyelid and lash cleansing as part of a regimen for blepharitis  steven e f brown february   novabay pharmaceuticals makes deal for flesheating bacteria cleanser san francisco business times retrieved june     novabay pharmaceuticals and virbac enter into a collaboration and license agreement for animal health  external linksedit companies portal wwwnovabaycom wwwavenovacom wwwdoctorsavenovacom wwwneutrophasecom wwwcellerxcom novabay pharmaceuticals inc the new york times v t e pharmaceutical companies of the united states current abbott laboratories acorda therapeutics aderis pharmaceuticals advaxis alcon alexion pharmaceuticals alkermes allergan amgen avax technologies baxter international biocryst pharmaceuticals biogen bioverativ biovest biovista bristolmyers squibb century pharmaceuticals ceragenix pharmaceuticals combe incorporated cortex pharmaceuticals cytosport cytrx danco laboratories eli lilly and company elorac endo pharmaceuticals par pharmaceutical galena biopharma genvec genentech gilead sciences institute for oneworld health intercept pharmaceuticals johnson  johnson ethicon janssen biotech mcneil consumer healthcare orthomcneil pharmaceutical kinetic concepts mallinckrodt mckesson corporation melinta therapeutics formerly ribx pharmaceuticals melior discovery mentholatum merck  co mylan myriad genetics northwest biotherapeutics norwich pharma services novabay pharmaceuticals ovation pharmaceuticals perrigo pfizer hospira searle pharmaceutical product development prasco laboratories procter  gamble proteon therapeutics purdue pharma quark pharmaceuticals regeneron repros therapeutics sarepta therapeutics savage laboratories sheffield pharmaceuticals spectrum pharmaceuticals tec laboratories teva pharmaceutical industries actavis tapi tiens biotech group titan pharmaceuticals trevena inc upshersmith laboratories valeant pharmaceuticals bausch  lomb ventria bioscience vertex pharmaceuticals west pharmaceutical services former alza amylin pharmaceuticals ariad pharmaceuticals biolex bradley pharmaceuticals cancervax cephalon cotherix covance covidien cubist pharmaceuticals cutter laboratories dnaprint genomics epix pharmaceuticals forest laboratories genta imclone systems ista pharmaceuticals king pharmaceuticals kv pharmaceutical leiner health products martek biosciences corporation s e massengill company miles laboratories naurex nereus pharmaceuticals nuvelo organon international ortho pharmaceutical osi pharmaceuticals parkedavis qualitest scheringplough smith kline  french sterling drug tanox tap pharmaceutical products trubion upjohn verus pharmaceuticals vion pharmaceuticals inc viropharma wyeth zonite products corporation list of pharmaceutical companies retrieved from httpsenwikipediaorgwindexphptitlenovabaypharmaceuticalsoldid categories companies listed on nyse mktpharmaceutical companies of the united statescompanies based in emeryville californiatechnology companies based in the san francisco bay areahealth care companies based in californiahidden categories articles needing additional references from june all articles needing additional referencespages using deprecated image syntaxall articles with unsourced statementsarticles with unsourced statements from june all articles with failed verificationarticles with failed verification from june articles containing potentially dated statements from april all articles containing potentially dated statements navigation menu personal tools not logged intalkcontributionscreate accountlog in namespaces article talk variants views read edit view history more search navigation main pagecontentsfeatured contentcurrent eventsrandom articledonate to wikipediawikipedia store interaction helpabout wikipediacommunity portalrecent changescontact page tools what links hererelated changesupload filespecial pagespermanent linkpage informationwikidata itemcite this page printexport create a bookdownload as pdfprintable version languages add links this page was last edited on  june  at  text is available under the creative commons attributionsharealike license additional terms may apply by using this site you agree to the terms of use and privacy policy wikipedia® is a registered trademark of the wikimedia foundation inc a nonprofit organization privacy policy about wikipedia disclaimers contact wikipedia developers cookie statement mobile view   bizapediacom  human validation companiespeopleproductsservicestrademarksaddressesphone book our system has detected a high number of page requests from your ip address please prove to us that you are a human to continue using our website please send me to the search subscription offer page after i successfully answer the word challenge bizapediapro searchperform unlimited searches via ouradvanced search form withbizapedia pro searchfind out more bizapediapro databuild custom data listsfor one or many stateswith bizapedia pro datafind out more  copyright   · bizapediacom · all rights reservedblogpro searchpro apicontact usterms of useprivacy policysitemapdesktop version novabay pharmaceuticals  wikipedia novabay pharmaceuticals from wikipedia the free encyclopedia jump to navigation search this article needs additional citations for verification please help improve this article by adding citations to reliable sources unsourced material may be challenged and removed june  learn how and when to remove this template message novabay pharmaceuticalsinc fighting superbugs type public traded as nyse mkt nby founded  founder ron najafi key people mark sieczkarek mba chairman  interim ceo tom paulson mba cfo glenn morovp sales and marketing avenova justin m hall esq senior vice president general counsel website novabaycom novabay pharmaceuticals inc is an emeryville california based clinicalstage biopharmaceutical company focused on developing novel fastacting synthetic antiinfectives compounds these compounds are designed to mimic the bodys defense system against infection the company is currently focused on products for the eye care market major products include avenova cleared by fda for lid and lash cleansing as part of a regimen for blepharitis and neutrophase used in treatment of necrotizing fasciitis contents  history  corporate governance  products  products on the market  products under development  references  external links historyedit novabay pharmaceuticals inc was founded by ron najafi an organic chemist who had previously worked for several pharmaceutical chemical and biotech companies in the us najafi became intrigued by hocl hypochlorous acid an antimicrobial substance produced by white blood cells while investigating the chemical reaction of white blood cells during oxidative burst cycle hocl and other chlorinecontaining chemicals fight invading microbes these natural substances rapidly oxidize the cell walls of bacteria and the protein coats of viruses rendering them inactive najafi started novabay pharmaceuticals in  to create a stable version of hoclcitation needed najafi chemistry nobel laureate herbert c brown and purdue university professor dale margerum recruited dr lu wang to novabay where she is now director of product development she was able to develop the stable version of pure hypochlorous acid without bleach impurities which became novabay’s first product neutrophasehypochlorous acid as a potential wound care agent part ii pdf  neutrophase® in chronic nonhealing wounds pdf  treatment of acute necrotizing fasciitis using negative pressure wound therapy and adjunctive neutrophase irrigation under the foam not in citation given and cleared by the food and drug administration in  the product successfully treats a variety of chronic nonhealing wounds without the use of standard antibiotics novabay announced two new products named cellerx™ for plastic surgery and ilid™ cleanser now avenova that was cleared by fda for lid and lash cleansing as part of a regimen for blepharitis novabay avenova has a low toxicity but kills eyelid bacteria in dry eye or blepharitis patients  corporate governanceedit as of april  update the members of the board of directors of novabay pharmaceuticals were paul e freiman xinzhou li paul li gail maderis t alex mcpherson md phd massimo radaelli phd mark sieczkarek mijia wu bob wu and xiaoyan liu henry liu productsedit products on the marketedit avenova formerly known as ilid cleanser  neutrophase  cellerx for plastic surgery products under developmentedit novabay developed a method for making a stable pure form of hypochlorous acid hocl a substance produced by the immune system as an effective first defense against microbial invaders the company calls their proprietary formulation neutrox the companys chemists also created a related family of compounds which the company calls aganocides the company is currently developing compounds with antibacterial and antiviral action potential applications include flesheating disease problems related to indwelling urinary catheters and common eye conditions compounds are also being developed for the veterinary market referencesedit  novabay avenova has a low toxicity but kills eyelid bacteria in dry eye or blepharitis patients   treatment of acute necrotizing fasciitis using negative pressure wound therapy and adjunctive neutrophase irrigation under the foam   nnff names novabays nby neutrophase its official flesheating disease wound cleanser   hypochlorous acid as a potential wound care agent part i pdf   k summary neutrophase® skin and wound cleaner otc pdf   novabay’s new advanced ilid cleanser has been cleared by the fda for cleaning removing debris and microbes from the skin around the eyes the eyelids and eyelashes eyelid and lash cleansing as part of a regimen for blepharitis  steven e f brown february   novabay pharmaceuticals makes deal for flesheating bacteria cleanser san francisco business times retrieved june     novabay pharmaceuticals and virbac enter into a collaboration and license agreement for animal health  external linksedit companies portal wwwnovabaycom wwwavenovacom wwwdoctorsavenovacom wwwneutrophasecom wwwcellerxcom novabay pharmaceuticals inc the new york times v t e pharmaceutical companies of the united states current abbott laboratories acorda therapeutics aderis pharmaceuticals advaxis alcon alexion pharmaceuticals alkermes allergan amgen avax technologies baxter international biocryst pharmaceuticals biogen bioverativ biovest biovista bristolmyers squibb century pharmaceuticals ceragenix pharmaceuticals combe incorporated cortex pharmaceuticals cytosport cytrx danco laboratories eli lilly and company elorac endo pharmaceuticals par pharmaceutical galena biopharma genvec genentech gilead sciences institute for oneworld health intercept pharmaceuticals johnson  johnson ethicon janssen biotech mcneil consumer healthcare orthomcneil pharmaceutical kinetic concepts mallinckrodt mckesson corporation melinta therapeutics formerly ribx pharmaceuticals melior discovery mentholatum merck  co mylan myriad genetics northwest biotherapeutics norwich pharma services novabay pharmaceuticals ovation pharmaceuticals perrigo pfizer hospira searle pharmaceutical product development prasco laboratories procter  gamble proteon therapeutics purdue pharma quark pharmaceuticals regeneron repros therapeutics sarepta therapeutics savage laboratories sheffield pharmaceuticals spectrum pharmaceuticals tec laboratories teva pharmaceutical industries actavis tapi tiens biotech group titan pharmaceuticals trevena inc upshersmith laboratories valeant pharmaceuticals bausch  lomb ventria bioscience vertex pharmaceuticals west pharmaceutical services former alza amylin pharmaceuticals ariad pharmaceuticals biolex bradley pharmaceuticals cancervax cephalon cotherix covance covidien cubist pharmaceuticals cutter laboratories dnaprint genomics epix pharmaceuticals forest laboratories genta imclone systems ista pharmaceuticals king pharmaceuticals kv pharmaceutical leiner health products martek biosciences corporation s e massengill company miles laboratories naurex nereus pharmaceuticals nuvelo organon international ortho pharmaceutical osi pharmaceuticals parkedavis qualitest scheringplough smith kline  french sterling drug tanox tap pharmaceutical products trubion upjohn verus pharmaceuticals vion pharmaceuticals inc viropharma wyeth zonite products corporation list of pharmaceutical companies retrieved from httpsenwikipediaorgwindexphptitlenovabaypharmaceuticalsoldid categories companies listed on nyse mktpharmaceutical companies of the united statescompanies based in emeryville californiatechnology companies based in the san francisco bay areahealth care companies based in californiahidden categories articles needing additional references from june all articles needing additional referencespages using deprecated image syntaxall articles with unsourced statementsarticles with unsourced statements from june all articles with failed verificationarticles with failed verification from june articles containing potentially dated statements from april all articles containing potentially dated statements navigation menu personal tools not logged intalkcontributionscreate accountlog in namespaces article talk variants views read edit view history more search navigation main pagecontentsfeatured contentcurrent eventsrandom articledonate to wikipediawikipedia store interaction helpabout wikipediacommunity portalrecent changescontact page tools what links hererelated changesupload filespecial pagespermanent linkpage informationwikidata itemcite this page printexport create a bookdownload as pdfprintable version languages add links this page was last edited on  june  at  text is available under the creative commons attributionsharealike license additional terms may apply by using this site you agree to the terms of use and privacy policy wikipedia® is a registered trademark of the wikimedia foundation inc a nonprofit organization privacy policy about wikipedia disclaimers contact wikipedia developers cookie statement mobile view novabay pharmaceuticals  wikipedia novabay pharmaceuticals from wikipedia the free encyclopedia jump to navigation search this article needs additional citations for verification please help improve this article by adding citations to reliable sources unsourced material may be challenged and removed june  learn how and when to remove this template message novabay pharmaceuticalsinc fighting superbugs type public traded as nyse mkt nby founded  founder ron najafi key people mark sieczkarek mba chairman  interim ceo tom paulson mba cfo glenn morovp sales and marketing avenova justin m hall esq senior vice president general counsel website novabaycom novabay pharmaceuticals inc is an emeryville california based clinicalstage biopharmaceutical company focused on developing novel fastacting synthetic antiinfectives compounds these compounds are designed to mimic the bodys defense system against infection the company is currently focused on products for the eye care market major products include avenova cleared by fda for lid and lash cleansing as part of a regimen for blepharitis and neutrophase used in treatment of necrotizing fasciitis contents  history  corporate governance  products  products on the market  products under development  references  external links historyedit novabay pharmaceuticals inc was founded by ron najafi an organic chemist who had previously worked for several pharmaceutical chemical and biotech companies in the us najafi became intrigued by hocl hypochlorous acid an antimicrobial substance produced by white blood cells while investigating the chemical reaction of white blood cells during oxidative burst cycle hocl and other chlorinecontaining chemicals fight invading microbes these natural substances rapidly oxidize the cell walls of bacteria and the protein coats of viruses rendering them inactive najafi started novabay pharmaceuticals in  to create a stable version of hoclcitation needed najafi chemistry nobel laureate herbert c brown and purdue university professor dale margerum recruited dr lu wang to novabay where she is now director of product development she was able to develop the stable version of pure hypochlorous acid without bleach impurities which became novabay’s first product neutrophasehypochlorous acid as a potential wound care agent part ii pdf  neutrophase® in chronic nonhealing wounds pdf  treatment of acute necrotizing fasciitis using negative pressure wound therapy and adjunctive neutrophase irrigation under the foam not in citation given and cleared by the food and drug administration in  the product successfully treats a variety of chronic nonhealing wounds without the use of standard antibiotics novabay announced two new products named cellerx™ for plastic surgery and ilid™ cleanser now avenova that was cleared by fda for lid and lash cleansing as part of a regimen for blepharitis novabay avenova has a low toxicity but kills eyelid bacteria in dry eye or blepharitis patients  corporate governanceedit as of april  update the members of the board of directors of novabay pharmaceuticals were paul e freiman xinzhou li paul li gail maderis t alex mcpherson md phd massimo radaelli phd mark sieczkarek mijia wu bob wu and xiaoyan liu henry liu productsedit products on the marketedit avenova formerly known as ilid cleanser  neutrophase  cellerx for plastic surgery products under developmentedit novabay developed a method for making a stable pure form of hypochlorous acid hocl a substance produced by the immune system as an effective first defense against microbial invaders the company calls their proprietary formulation neutrox the companys chemists also created a related family of compounds which the company calls aganocides the company is currently developing compounds with antibacterial and antiviral action potential applications include flesheating disease problems related to indwelling urinary catheters and common eye conditions compounds are also being developed for the veterinary market referencesedit  novabay avenova has a low toxicity but kills eyelid bacteria in dry eye or blepharitis patients   treatment of acute necrotizing fasciitis using negative pressure wound therapy and adjunctive neutrophase irrigation under the foam   nnff names novabays nby neutrophase its official flesheating disease wound cleanser   hypochlorous acid as a potential wound care agent part i pdf   k summary neutrophase® skin and wound cleaner otc pdf   novabay’s new advanced ilid cleanser has been cleared by the fda for cleaning removing debris and microbes from the skin around the eyes the eyelids and eyelashes eyelid and lash cleansing as part of a regimen for blepharitis  steven e f brown february   novabay pharmaceuticals makes deal for flesheating bacteria cleanser san francisco business times retrieved june     novabay pharmaceuticals and virbac enter into a collaboration and license agreement for animal health  external linksedit companies portal wwwnovabaycom wwwavenovacom wwwdoctorsavenovacom wwwneutrophasecom wwwcellerxcom novabay pharmaceuticals inc the new york times v t e pharmaceutical companies of the united states current abbott laboratories acorda therapeutics aderis pharmaceuticals advaxis alcon alexion pharmaceuticals alkermes allergan amgen avax technologies baxter international biocryst pharmaceuticals biogen bioverativ biovest biovista bristolmyers squibb century pharmaceuticals ceragenix pharmaceuticals combe incorporated cortex pharmaceuticals cytosport cytrx danco laboratories eli lilly and company elorac endo pharmaceuticals par pharmaceutical galena biopharma genvec genentech gilead sciences institute for oneworld health intercept pharmaceuticals johnson  johnson ethicon janssen biotech mcneil consumer healthcare orthomcneil pharmaceutical kinetic concepts mallinckrodt mckesson corporation melinta therapeutics formerly ribx pharmaceuticals melior discovery mentholatum merck  co mylan myriad genetics northwest biotherapeutics norwich pharma services novabay pharmaceuticals ovation pharmaceuticals perrigo pfizer hospira searle pharmaceutical product development prasco laboratories procter  gamble proteon therapeutics purdue pharma quark pharmaceuticals regeneron repros therapeutics sarepta therapeutics savage laboratories sheffield pharmaceuticals spectrum pharmaceuticals tec laboratories teva pharmaceutical industries actavis tapi tiens biotech group titan pharmaceuticals trevena inc upshersmith laboratories valeant pharmaceuticals bausch  lomb ventria bioscience vertex pharmaceuticals west pharmaceutical services former alza amylin pharmaceuticals ariad pharmaceuticals biolex bradley pharmaceuticals cancervax cephalon cotherix covance covidien cubist pharmaceuticals cutter laboratories dnaprint genomics epix pharmaceuticals forest laboratories genta imclone systems ista pharmaceuticals king pharmaceuticals kv pharmaceutical leiner health products martek biosciences corporation s e massengill company miles laboratories naurex nereus pharmaceuticals nuvelo organon international ortho pharmaceutical osi pharmaceuticals parkedavis qualitest scheringplough smith kline  french sterling drug tanox tap pharmaceutical products trubion upjohn verus pharmaceuticals vion pharmaceuticals inc viropharma wyeth zonite products corporation list of pharmaceutical companies retrieved from httpsenwikipediaorgwindexphptitlenovabaypharmaceuticalsoldid categories companies listed on nyse mktpharmaceutical companies of the united statescompanies based in emeryville californiatechnology companies based in the san francisco bay areahealth care companies based in californiahidden categories articles needing additional references from june all articles needing additional referencespages using deprecated image syntaxall articles with unsourced statementsarticles with unsourced statements from june all articles with failed verificationarticles with failed verification from june articles containing potentially dated statements from april all articles containing potentially dated statements navigation menu personal tools not logged intalkcontributionscreate accountlog in namespaces article talk variants views read edit view history more search navigation main pagecontentsfeatured contentcurrent eventsrandom articledonate to wikipediawikipedia store interaction helpabout wikipediacommunity portalrecent changescontact page tools what links hererelated changesupload filespecial pagespermanent linkpage informationwikidata itemcite this page printexport create a bookdownload as pdfprintable version languages add links this page was last edited on  june  at  text is available under the creative commons attributionsharealike license additional terms may apply by using this site you agree to the terms of use and privacy policy wikipedia® is a registered trademark of the wikimedia foundation inc a nonprofit organization privacy policy about wikipedia disclaimers contact wikipedia developers cookie statement mobile view china pioneer pharma holdings ltd hk people  reuterscom x edition united states africa américa latina عربي argentina brasil canada  deutschland españa france india italia  méxico россия united kingdom united states china pioneer pharma holdings ltd hk related topics stocksstock screenermarket dataconsumer noncyclicalsdrug retailers overview news key developments people charts financials analysts research pulse hk on hong kong stock hkd  jul  change  chg hk  prev close hk open hk days high hk days low hk volume  avg vol  wk high hk wk low hk summary name age since current position xinzhou li   executive chairman of the board mengjun zhu   chief executive officer executive director yi xue   chief financial officer wenfei huang   general manager  ophthalmology business unit gang shi   general manager  fleet  domestic products business unit juming wang   general manager  polichem business unit tao wang   general manager  easyhaler  neutrophase business unit xiuyan yang   general manager  aw business unit weijuan lai   director  covex vinpocetine business unit xuefeng liu   business development director jin shao   director  difene business unit rongrong wang   national director  commerce department le min   company secretary yinping wang   nonexecutive director mijia wu   nonexecutive director chanshu lai   independent nonexecutive director chi hung wong   independent nonexecutive director zhonghai xu   independent nonexecutive director » insider trading biographies name description xinzhou li mr li xinzhou serves as executive chairman of the board of china pioneer pharma holdings ltd mr li is the founder of our group and joined pioneer pharma shareholding company limited “pioneer pharma” our initial corporate entity in july  as its general manager and chairman responsible for managing the operations and planning and formulating our group’s strategies mr li has over  years of experience in the pharmaceutical services industry under mr li’s leadership our group has received numerous awards and recognitions in addition mr li has been the asiapacific advisor to the board of directors of novabay one of our suppliers and also a company in which we held approximately  equity interest as at the  december  since october  providing his vision and strategic thinking for the entry of novabay’s products into china and southeast asia markets as well as thoughts with respect to the collaboration between novabay and our group mr li has become the chairman of the board of covex since july  one of our suppliers and also a nonwhollyowned subsidiary of our group mr li also has over  years of experience in international trading and management prior to joining our group mr li worked at the hainan branch of sumitomo corporation from august  to august  mr li worked as an english translator at china offshore oil nanhai west corporation and from july  to august  he worked as an english teacher at jianghan oil field dongfanghong high school mr li had held various positions in trade associations throughout the years he was the vice chairman of the hainan general chamber of commerce and the standing vice president of hainan hubei chamber of commerce he had also served as a member of the chinese people’s political consultative conference hainan committee mr li graduated from jianghan petroleum normal school with a diploma in english in july  he also studied at the china europe international business school mengjun zhu mr zhu mengjun is the chief executive officer executive director of china pioneer pharma holdings ltd he joined the group in march  and served as pioneer pharmas chief accountant and manager of finance department  he is a director of pioneer singapore pioneer medical hk and pioneer medident he has over  years of experience in accounting and corporate finance he was with shanghai yangtze nonferrous metals co ltd he holds master of accountancy from the chinese university of hong kong in december  he was awarded a certificate of accounting professional midlevel by shanghai finance bureau in september  and has been a member of the shanghai institute of certified public accountants since april  yi xue mr xue yi has been appointed as the chief financial officer of the company he joined the group in january  and served as the manager of the audit department of pioneer pharma between january  and january  and was appointed as the manager of the finance department of pioneer pharma since february  mr xue was appointed as the company’s deputy financial officer since february  responsible for assisting chief financial officer with finance and accounting management mr xue is also an executive director of the company’s whollyowned subsidiary naqu area pioneer pharma co ltd mr xue has over  years of experience in the accounting and auditing field prior to joining the group mr xue worked at sichuan dazhou foods company mr xue obtained a bachelor’s degree in accounting from southwestern university of finance and economics in june  and obtained the qualification of medium level accountant in august  wenfei huang ms huang wenfei serves as general manager  ophthalmology business unit of china pioneer pharma holdings ltd since october  ms huang joined our group in  and worked as a manager of our commerce department between  and  and a sales director in  she was appointed as our deputy general manager in october  and a director of pioneer pharma in april  responsible for various aspects of our business including human resources administration product registration purchase logistics product quality commerce and government affairs in september  ms huang was promoted as a general manager of our ophthalmology business unit responsible for the promotion and sales of all the ophthalmic products of our group ms huang has nearly  years of working experience in the pharmaceutical industry prior to joining our group she worked at shanghai xudong haipu pharmaceutical co ltd and shanghai eighteenth pharmaceutical ms huang obtained an executive master’s degree in business administration by tongji university in march  gang shi mr shi gang serves as general manager  fleet  domestic products business unit of china pioneer pharma holdings ltd since may  mr shi joined our group in march  and was appointed as our sales director in march  a deputy general manager in may  and a director of pioneer pharma in april  mr shi has been responsible for the sales and marketing of our products in particular in southern yangtze river area in september  mr shi was promoted as the general manager of fleet  domestic products business unit and is responsible for the promotion and sales of fleet and domestic products of our group he has over  years working experience in the pharmaceutical industry mr shi was a doctor at shanghai jing’an district centre hospital starting in july  mr shi was awarded with a bachelor’s degree in basic medicine science by shanghai medicine college in july  and an executive master’s degree in business administration by fudan university in june  juming wang mr wang juming serves as general manager  polichem business unit of china pioneer pharma holdings ltd mr wang joined our group in september  and was appointed as our general manager of polichem business unit and is responsible for the promotion and sales of polichem products of our group mr wang has over  years of working experience in pharmaceutical industry prior to joining the group mr wang worked at shaanxi sino german hiympt pharmaceutical co ltd from  to  and worked at shenzhen jianmin pharmaceutical co ltd from  to  from  to  mr wang worked in shenzhen xiannuo pharmaceutical factory from  to  mr wang worked in suzhou fourth pharmaceutical factory preparation plant mr wang was graduated from the shaanxi university chinese medicine school with bachelor’s degree in medicine in july  tao wang mr wang tao serves as general manager  easyhaler  neutrophase business unit of china pioneer pharma holdings ltd since january  mr wang joined our group in september  and worked as a product manager and marketing manager between september  and december  mr wang was appointed as our marketing director in january  responsible for formulating and implementing marketing plans and strategies training and supporting sales team in marketing activities as well as preparing promotion tools in september  mr wang was promoted as the general manager of easyhaler  neutrophase products business unit and is responsible for the promotion and sales of easyhaler series products and neutrophase mr wang has over  years working experience in the pharmaceutical industry prior to joining our group mr wang worked at shanghai hanyin pharmaceutical co ltd between january  and september  mr wang was awarded with a bachelor’s degree in clinical medicine by xinxiang medical university in july  and an executive master’s degree in business administration from antai college of economics and management of shanghai jiao tong university in december  xiuyan yang ms yang xiuyan serves as general manager  aw business unit of china pioneer pharma holdings ltd since january  ms yang joined our group in december  and worked as the manager for shandong and northern china area between  and  she was appointed as our deputy general manager and sales director in january  and was responsible for the sales and marketing of our group in particular in the northern yangtze river area in september  ms yang was promoted as a general manager of aw business unit and is responsible for the promotion and sales of alfa wassermann’s products of our group she has nearly  years working experience in the pharmaceutical industry prior to joining our group ms yang worked at boli people’s hospital of heilongjiang province ms yang was awarded with a bachelor’s degree in clinical medicine by the binzhou medical university in july  weijuan lai ms lai weijuan serves as director  covex vinpocetine business unit of china pioneer pharma holdings ltd ms lai joined the group in  and worked as the chief representative responsible for market analysis and purchasing management of vinpocetine api and the overseas investment of our group from  to march  ms lai was appointed as the general manager of covex sa in april  in october  ms lai was promoted as the director of covex vinpocetine business unit and is responsible for the operation of covex sa and the promotion and sales of vinpocetine api in china xuefeng liu mr liu xuefeng serves as business development director of china pioneer pharma holdings ltd since april  he joined the group in september  he has over nine years of working experience in the pharmaceutical industry he was a medical representative at astrazeneca wuxi trading co ltd january august  and assistant secretary general and head of international council at chinese society of biochemistry and molecular biology he was with hangzhou zhongmei huadong pharmaceutical co ltd he holds bachelor in biopharming by china pharmaceutical university in july  and studied master in microbiology and biochemical pharmacy at shanghai institute of pharmaceutical industry in july  between august  and september  he worked at hangzhou zhongmei huadong pharmaceutical co ltd mr liu was awarded with a bachelor’s degree in biopharming by china pharmaceutical university in july  and a master’s degree in microbiology and biochemical pharmacy by shanghai institute of pharmaceutical industry in july  jin shao mr shao jin serves as director  difene business unit of china pioneer pharma holdings ltdmr shao joined our group in july  and worked as a sales supervisor of south china area and a manager of greater southern china from  to  he was appointed as the otc director in  in september  mr shao was promoted as the director of difene business unit and is responsible for the promotion and sales of difene of our group mr shao has over  years of experience in the pharmaceutical industry mr shao received an executive master’s degree in business administration from zhongnan university of economics and law in  rongrong wang ms wang rongrong serves as national director  commerce department of china pioneer pharma holdings ltd ms wang joined our group in july  and worked as a manager of commerce department from september  to august  in september  ms wang was promoted as our national director of commerce department ms wang is mainly responsible for bidding pricing receivables management and channel management and other business related work ms wang has more than  years of working experience in pharmaceutical industry prior to joining the group ms wang worked in hainan sanye pharmaceutical group ms wang received a bachelor’s degree in biological engineering in june  and a licensed pharmacist qualification certificate in  le min mr min le serves is the company secretary of china pioneer pharma holdings ltd mr min joined our group in july  and serves as the secretary of the board mr min is a prc nonpractising certified public accountant and has over  years of experience in the financing and accounting field mr min worked as the chief accountant at carrefour china management  consulting service co ltd between october  to june  mainly responsible for preparing budgets and financial closing and designing streamlining and improving financial and accounting process prior to that he worked at shanghai zhonghua certified public accountants as a project manager between march  and september  mainly responsible for annual financial auditing and financial consulting mr min graduated from the east china university of science and technology with a bachelor’s degree in environmental engineering in june  and from the tong ji university with a master’s degree in environmental engineering in march  yinping wang mr wang yinping is the nonexecutive director of the company he is very experienced in corporate management he joined sinochem import and export corporation now known as china sinochem group corporation “sinochem group” in  since then he had taken various senior positions within the group of sinochem group until  when he resigned as the vice president of sinochem group during the  years he spent with sinochem group mr wang had taken the following major positions from  to  mr wang was the vice general manager of sinochem group hainan company from  to  he was the general manager of sinochem group pudong companyfrom  to  he was the vice general manager of china foreign economy and trade trust co ltd a member company of the group of sinochem group from  to  he was the general manager of the human resources department of sinochem group during this period he was also the vice president of sinochem group from  to  he was the general manager of sinochem international trade co ltd now known as sinochem international corporation a company listed on the shanghai stock exchange with the stock code of  during the same period he was also the director of the board of bank of communications co ltd a company listed on the hong kong stock exchange with the stock code of  and on the shanghai stock exchange with the stock code of  in  he was reappointed as the vice president of sinochem group during  to  he was also the chairman of the board of china foreign economy and trade trust co ltd the chairman of the board and general manager of sinochem lantian co ltd and the chairman of the board of zhejiang int’l group co ltd a company listed on the shenzhen stock exchange with the stock code of  mr wang graduated from renmin university of china with a bachelor’s degree in law in  he also received an mba degree from china europe international business school in  mijia wu mr wu mijia serves as nonexecutive director of china pioneer pharma holdings ltd since october   he has over  years of experience in finance and investment he has been the managing director of shanghai ceton investment management since june  prior to that he served as director at ubs ag hong kong branch mayaugust  and vice president of bnp paribas hong kong september december  he was an assistant vice president at abn amro bank china co ltd october june  he holds bachelor in international business from guangdong university of foreign studies in june  master in business administration from university of manchester in june  and executive master in business administration from cheung kong graduate school of business in october  chanshu lai mr lai chanshu serves as an independent nonexecutive director of china pioneer pharma holdings ltd since october   he served as general manager of alcon pharmaceuticals ltd january february  he holds bachelor in pharmacy from taipei medical university in june  he has been a registered pahrmacist with the department of health of republic of china since april  mr lai is a member of the remuneration committee and a member of the nomination committee chi hung wong mr wong stanley chi hung serves as an independent nonexecutive director of china pioneer pharma holdings ltd since october   he serves as independent nonexecutive director of huafeng group holdings limited since july  and independent nonexecutive director of great wall motor company limited since november  he serves as chief financial officer of hongri international holdings company limited since november  he was chief executive officer of china biologic products inc march may  he is a fellow of the hong kong institute of certified public accountants and a fellow member of the association of chartered certified accountants he holds bachelor in accounting from university of kent and an emba from peking university he is also a qualified independent director recognised by the shanghai stock exchange mr wong is the chairman of the audit committee zhonghai xu mr xu zhonghai serves as an independent nonexecutive director of china pioneer pharma holdings ltd since october   he has been a professor in chemistry at yueyang vocational technical college since march  prior to that he worked at tibet autonomous region health department and chief inspector at tibet autonomous regional health and epidemic prevention station he holds bachelor in chemistry from hunan normal university in july  and master in analytical chemistry in january  mr xu is the chairman of the remuneration committee a member of the audit committee and a member of the nomination committee basic compensation name fiscal year total xinzhou li  mengjun zhu  yi xue  wenfei huang  gang shi  juming wang  tao wang  xiuyan yang  weijuan lai  xuefeng liu  jin shao  rongrong wang  le min  yinping wang  mijia wu  chanshu lai  chi hung wong  zhonghai xu  as of   dec  options compensation name options value xinzhou li   mengjun zhu   yi xue   wenfei huang   gang shi   juming wang   tao wang   xiuyan yang   weijuan lai   xuefeng liu   jin shao   rongrong wang   le min   yinping wang   mijia wu   chanshu lai   chi hung wong   zhonghai xu   insider trading » full list on insider trading related topics stocksstock screenermarket dataconsumer noncyclicalsdrug retailers mijia wu  ceo founder businessman  profile directorpedianet  list of ceos founders board members and company directors mijia wu check out list of companies and businesses related to mijia wu find out mijia wu address and contact details view other people related to mijia wu  coworkers colleagues companions etc address co novabay pharmaceuticals inc  horton street suite  emeryville  ca companies related to mijia wu cikcompany namepositioncompany addressnovabay pharmaceuticals incdirector  powell street suite  emeryville  mijia wu on the web persons related to mijia wu  novabay pharmaceuticals incnamepositioncitymark brian andersoncso emeryvillemark brian andersonemeryvillekeith r bleysvp product development emeryvillecharles cashiondirector emeryvillecashion charlesemeryvillechina pioneer pharma holdings ltd owner grand caymanchina pioneer pharma holdings ltd owner grand cayman cayman islandsanthony dailleydirector emeryvilleanthony dailleydirector emeryvilleanthony dailleydirector emeryvillepaul e freimandirector emeryvillepaul e freimandirector emeryvillepaul e freimandirector emeryvillejian ping fu owner burwood australiamaderis gailemeryvillejustin hallsvp general counsel emeryvilleharry f hixson jrdirector emeryvillerussell a hoonsenior vice president emeryvillehall justinemeryvillebehzad khosrovisvp product development emeryvillebehzad khosrovivp research and development emeryvillebehzad khosrovisvp product development  cao emeryvillexinzhou lidirector shanghai pr of chinaxinzhou li owner shanghai pr of chinaxinzhou li owner shanghaixiaoyan liudirector emeryvilleyonghao madirector emeryvillegail j maderisdirector san franciscogail j maderisdirector emeryvillesieczkarek markemeryvilleradaelli massimoemeryvillet alex mcphersondirector emeryvillet alex mcphersondirector emeryvillebob wu mijiaemeryvillewu mijiaemeryvillenajafi family trust dated september  emeryvilleramin najafichief executive officer emeryvilleramin najafichief executive officer emeryvilleramin najaficheif executive officer emeryvilleramin najafichief executive officer emeryvillenaqu area pioneer pharma co ltd owner shanghai pr of chinajohn james oreillychief financial officer emeryvillejohn james oreillysvp business and corporate dev emeryvillejohn james oreillyemeryvillefreiman paulemeryvillethomas j paulsoncfo thomas j paulsoncfo emeryvillethomas j paulsonchief financial officer emeryvillethomas j paulsoncfo emeryvillethomas j paulsoncfo emeryvillepioneer pharma hong kong co ltd owner kowloonpioneer pharma hong kong co ltd owner lai chi kok kowloon hkpioneer pharma singapore pte ltd owner singaporepioneer pharma singapore pte ltd owner singaporemassimo radaellidirector cambridgemassimo radaellidirector emeryvilleron najafi raminemeryvillewu royemeryvillecolin scottvp clinical research and deve emeryvillemark m sieczkarekceo san carlosmark m sieczkarekdirector emeryvilledavid w stromansvp ophthalmic product devt emeryvillealex mcpherson temeryvillemcpherson temeryvillepaulson thomasemeryvillezavodnick toddemeryvillewicks tonyemeryvillerobert r tuftsdirector emeryvilletony ds wicksdirector emeryvilletony ds wicksdirector emeryvilletony ds wicksdirector emeryvillemijia wudirector emeryvilleroy j wusvp bus  corp development roy j wusvp bus  corp development emeryvilleroy j wuemeryvillehenry liu xiaoyanemeryvilleliu xiaoyanemeryvillepaul li xinzhouemeryvilletodd erik zavodnickdirector pleasanton potentially same personnamecitycountrywu mijiaemeryvilleca mijia wu  executive bio compensation history and contacts  equilar atlas   log in  sign up x   as featured in mijia wu board member at novabay pharmaceuticals inc view full profile are you mijia wu claim your profile   sign up for equilar atlas and view mijia wus full profile with equilar atlas you can identify corporate executives in mijia wus network and community follow changes in mijia wus employment and moneyinmotion connect with mijia wu through your network of contacts mijia wus executive work history current board member novabay pharmaceuticals inc past to view mijia wus complete executive work history sign up now age      mijia wus biography mijia bob wu mba has served as a director of novabay since january  since june  mr wu has been the managing director of china kington an affiliated entity of china kington investment co ltd which  acted as the sole placement agent and received a commission for a  million private placement of novabay common stock and warrants to purchase common stock in may   facilitated a bridge loan for the company in the aggregate amount of  million in august  in consideration for which china kington was granted among other things the right to appoint two  new members to the companys board pursuant to  read more mijia bob wu mba has served as a director of novabay since january  since june  mr wu has been the managing director of china kington an affiliated entity of china kington investment co ltd which  acted as the sole placement agent and received a commission for a  million private placement of novabay common stock and warrants to purchase common stock in may   facilitated a bridge loan for the company in the aggregate amount of  million in august  in consideration for which china kington was granted among other things the right to appoint two  new members to the companys board pursuant to which mr wu is currently up for stockholder election as a director nominee  acted as the sole placement agent and received a commission for three  securities purchase agreements for the sale of  shares of the companys common stock to accredited investors in february  and  acted as the sole placement agent and received a commission for an  million private placement of novabay common stock and warrants to purchase common stock which closed in two  tranches may  and august  concurrently mr wu serves as the managing director of shanghai ceton investment management co ltd since october  he has also been the nonexecutive director of china pioneer pharma holdings limited china pioneer pharma the companys largest stockholder holding approximately  of novabays total common stock outstanding and indirect owner of pioneer pharma hong kong company limited pioneer hong kong a whollyowned subsidiary of china pioneer pharma previously mr wu served as director at ubs ag hong kong branch in  and vice president of bnp paribas hong kong from  to  he was also the assistant vice president at abn amro bank china co ltd from  to  he holds an mba from manchester business school university of manchester and an executive mba from cheung kong graduate school of business he brings to the board over a decade of valuable experience in finance and investments source novabay pharmaceuticals inc on    sign up for equilar atlas and view mijia wus full profile by accessing equilar atlas you can view bios network salary and wealth events of industryleading executives like mijia wu more specifically youll be able to identify corporate executives in mijia wus network and community follow changes in mijia wus employment and moneyinmotion connect with mijia wu through your network of conections view full profile   search for over  executive profiles bio example mijia wu mijia wus connections  sign up now to view mijia wus  connections » xinzhou li former board member novabay pharmaceuticals inc todd e zavodnick president international zeltiq aesthetics inc massimo radaelli former board member ariad pharmaceuticals inc justin m hall former senior vice president and general counsel novabay pharmaceuticals inc mark m sieczkarek chief executive officer and chairman of the board novabay pharmaceuticals inc xiaoyan liu board member novabay pharmaceuticals inc thomas j paulson former vice president finance and chief financial officer avigen paul e freiman board member novabay pharmaceuticals inc t alex mcpherson former board member novabay pharmaceuticals inc popular profiles sign up now to view more executive profiles » thomas j lynch executive chairman te connectivity ltd john j kita evp and cfo a o smith carl g annessa evp and coo hornbeck offshore services inc elon r musk ceo and chairman tesla michael c montgomery board member nmi holdings inc × claim your profile coming soon interested in updating your biography and work history were working on making it happen well email you when this feature is available please enter valid email address done thank you for your interest ok browse executive profiles  a  b  c  d  e  f  g  h  i  j  k  l  m  n  o  p  q  r  s  t  u  v  w  x  y  z equilar homepage equilar atlas equilar insight equilar boardedge equilar engage research services knowledge network about us login ï¿½  equilar all rights reserved privacy policy  marshall street redwood city ca   phone    fax   mi jia wu mba  biography log in email password remember forgot password  become a member for free sign up sign up new membersign up for free new customerdiscover our portfolios united states united kingdom france deutschland schweiz de suisse fr settings dynamic quotes  offon markets equities north americaeuropeasiaoceaniamiddle east» more equities indexes dow jonessp nasdaq tsx compftse » more indexes currency  forex eur  usdgbp  usdusd  jpyusd  cadaud  usd» more currencies commodities goldcrude oil wticrude oil brentsilverplatinum» more commodities news latest news companiesmarketseconomycurrency  forexcommoditiesinterest ratesbusiness leadersfinancial calendareconomic calendar listed company analyst recorumorsiposcapital markets transactionsnew contractsprofits warningsappointmentspress releaseseventscorporate actions sector news energybasic materialsindustrialsconsumer cyclicalconsumer noncyclicalfinancialshealthcaretechnologytelecommunications servicesutilities analysis all analysiscommentariesindex analysisstock trading strategiescommodity analysisforex analysis stock picks all stock picks portfolios my portfolio virtual portfolios traders portfolios european portfoliousa portfolioasian portfolio screeners market screener homefundamental analyse top investor ratingtop trading ratingtop consensusgrowth stocksyield stockslow valuations technical analysis oversold stocksoverbought stocksclose to resistancesclose to supportsaccumulation phasemost volatile stocks watchlists my watchlists watchlists top lists yield stocksgrowth stocksundervalued stocks top  flop top news most read newshot news top fundamentals top capitalizationtop yieldtop pertop consensustop fundamentals top technicals top rsiunusual volumestop gapstop stim top movers top usatop canadatop uktop germanytop europetop asia tools market screenerdynamic chartfinancial calendareconomic calendarsector researchcurrency converter our services premium accessdiscover our services traders homepage    news    business leaders    business leaders biography business leaders latest newscompaniesmarketseconomy  forexcommoditiesinterest ratesbusiness leadersfinance professionalscalendarsectors homeall newsmost read newsbusiness leaders biography mi jia wu mba age  public asset   usdlinked companies  china pioneer pharma holdings ltd  novabay pharmaceuticals inc summary  mr mijia wu is owner at pioneer pharma singapore pte ltdhe is on the board of directors at novabay pharmaceuticals inc and china pioneer pharma holdings ltd mr wu was previously employed as vice president by bnp paribas hong kong branch and assistant vice president by abn amro bank china co ltdhe also served on the board at ubs ag hong kong branchhe received his undergraduate degree from guangdong university of foreign studies an mba from manchester business school and an mba from cheung kong graduate school of business current positions of mi jia wu mba  nametitle since china pioneer pharma holdings ltddrug retailers nonexecutive director  novabay pharmaceuticals incbiotechnology  medical research nonindependent director pioneer pharma singapore pte ltd owner  holdings of mi jia wu mba  nameequitiesvaluation novabay pharmaceuticals inc nby biotechnology  medical research  usd mi jia wu mba personal network  namelinked companies xin zhou li china pioneer pharma holdings ltdnovabay pharmaceuticals incpioneer pharma singapore pte ltd meng jun zhu china pioneer pharma holdings ltdpioneer pharma singapore pte ltd thomas j paulson novabay pharmaceuticals inc paul e freiman novabay pharmaceuticals inc mark m sieczkarek novabay pharmaceuticals inc gail j maderis novabay pharmaceuticals inc jack j mcgovern novabay pharmaceuticals inc yin ping wang china pioneer pharma holdings ltd chi hung wong china pioneer pharma holdings ltd le min china pioneer pharma holdings ltd most read news   li kashing  li kashings cki to buy german energy metering firm ista djbernard arnault  lvmhs profit rises  in first half  rupert murdoch  as murdoch waits sky cuts operating costs to protect profits djmeg whitman  meg whitman steps down from hp board djnelson peltz  procter  gamble peltz spar on results  wsj  carlos slim  hutchisons drei buys tele to rival carlos slim in austria djdavid simon  executive pay falls for big mall owners as retail storm rages on djjeff bezos  amazons jeff bezos becomes worlds richest person djelon musk  top company news of the day a elon musk  teslas musk hands over first model  electric cars to early buyers more news   people and ownership     advertisement mi jia wu mba  connections  novabay pharmaceuticals inc xin zhou lithomas j paulsonpaul e freimanmark m sieczkarekgail j maderisjack j mcgovern opexa therapeutics inc gail j maderis china pioneer pharma holdings ltd xin zhou limeng jun zhuyin ping wangchi hung wongle min yida china holdings ltd yin ping wang western potash corp yin ping wang covex sa xin zhou li pioneer pharma hong kong co ltd xin zhou li fe medical inc mark m sieczkarek pioneer pharma singapore pte ltd xin zhou limeng jun zhu western resources corp wyoming yin ping wang pioneer medident se asia pte ltd xin zhou limeng jun zhu xiantao city pioneer pharma co ltd xin zhou li hong kong institute of certified public accountants chi hung wong naqu area pioneer pharma co ltd xin zhou li phytos inc paul e freiman trinity biosystems inc gail j maderis antiva biosciences inc gail j maderis tian tian ltd xin zhou li pioneer medical hk co ltd meng jun zhu shenyang zhiying pharmaceutical co ltd yin ping wang popular business leaders  bernard arnault mary barra luc besson jeff bezos lloyd blankfein michael bloomberg yannick bolloré warren buffett jeanpaul clozel gary cohn marc de lacharrière jamie dimon ralph dommermuth sebastian ebel john edwards david einhorn jeff fettig mark fields carlos ghosn david henry carl icahn li kashing michel landel daniel loeb jack ma lakshmi mittal rupert murdoch elon musk peter nicholas xavier niel john paulson nelson peltz georges plassat hasso plattner thomas rabe giuseppe recchi wolfgang reitzle wilbur ross charles schwab igor sechin carlos slim pascal soriot george soros rupert stadler bernard tapie john williamson thomas wilson dieter zetsche mark zuckerberg az business leaders traderscom marketsnewsanalysisstock picksportfoliosscreenerswatchliststop  floptoolsour servicesabout surperformance sascontact usadvertiselegal informationsabout usstay connected facebooktwitterpartners börse aktien kurse und nachrichtenbest tweets copyright   surperformance all rights reserved slave microsoft personalized ad preferences to opt out of personalized ads in this browser your browser history must allow firstparty and thirdparty cookies and you must have your browsing experience set to not delete browsing history on exit instructions for enabling cookies and configuring your browsing history may be available in your browsers settings privacy or help documentation sign in hold on… we’re sorry but this didn’t work you can’t turn off personalized ads right now because your browser is currently blocking thirdparty cookies we can help you fix this issue let’s get started depending on what browser you use open options or settings make sure that thirdparty cookies are not blocked anymore to find out how search your browser’s help revisit httpchoicemicrosoftcomoptout and then on the “personalized ads in this browser” tile click off ext about our ads to create a more customized online experience some of the ads you may receive on microsoft websites and apps are tailored to your previous activities searches and site visits youre in control and heres where you can make the advertising choice thats right for you ext where can i learn more about advertising on microsoft websites and apps microsoft partners with oath appnexus and other third party service providers to help present customized content and display advertisements on msn outlookcom and other websites and apps microsoft also delivers search ads to bing and our search syndication partners learn more about microsoft’s privacy practices here you can learn more about interestbased ads from oath and appnexus in their privacy statements oath and appnexus what choices do i have about interestbased advertising on this page you can opt out of receiving interest based advertising from microsoft you can also opt out of receiving interestbased advertising from all selfregulatory members including microsoft oath appnexus and other third party ad networks at the following sites in the us digital advertising alliance daa in europe european interactive digital advertising alliance edaa in canada ad choices digital advertising alliance of canada daac you can control interestbased advertising in windows apps by turning off the advertising id in windows settings more choices do you want personalized ads from other companies questions if you have a privacy question or a question for the chief privacy officer of microsoft please contact us by using our web form we will respond to questions within  days ext personalized ads in this browser off optout is currently unavailable please try again later control the personalized ads setting for this web browser learn more if you want microsoft to show ads that might be relevant to you click on to show “generic” ads click off ext personalized ads wherever i use my microsoft account off sign in to change optout is currently unavailable please try again later control the personalized ads setting that applies when you are signed in on any computer or device with your microsoft account including windows windows phone xbox and other devices learn more if you want microsoft to show ads that might be relevant to you click on to show “generic” ads click off if you choose “generic” ads and use a browser your choice applies to everyone when using that browser as long as you do not clear your cookies ext personalized ads in windows in your windows settings you can turn off personalized ads that appear in apps on this device you’ll still see ads but they won’t be personalized anymore if you have windows  access the charms by touching or moving your pointer to the right edge of the screen click or tap settings and then click or tap change pc settings click or tap privacy and then turn off let apps use my advertising id for experiences across apps if you have windows  click or tap the start button click or tap settings click or tap privacy and then turn off let apps use my advertising id for experiences across apps if you have a windows mobile device go to settings tap on privacy tap on advertising id and then turn off let apps use my advertising id for experiences across apps if you want to turn off personalized ads from microsoft wherever you use your microsoft account including apps on windows windows phone xbox and other devices you can do so by selecting the microsoft account option above ext legal privacy  cookies   microsoft mijia u wu  glendora ca  intelius sign in we found mijia u wu in glendora ca mijia u wu intelius found that mijia u wu from glendora ca we have connected them to  addresses  phones and  relatives or associates get report now mijia has lived in glendora ca emeryville ca mijia u wu professional status director at novabay pharmaceuticals inc get report now want to know more about mijia get a comprehensive background report find full phone numbers and other contact information when available all from billions of available public records continue below for more details about mijia or use our people search engine to find others get background check on mijia u wu get a criminal check on mijia u wu get a public record report on mijia u wu get a people search report on mijia u wu mijia u wus contact information known cities lived in find out where mijia u wu has lived as well as mijia u wus phone numbers and email addresses mijia u wu has lived in  states california address for mijia u wu  s t r glendora ca has lived in glendora ca emeryville ca get full address report phone numbers associated with mijia u wu get full phone report email addresses associated with mijia u wu get email report mijia u wus professional information information regarding mijia u wus professional history find out previous places mijia u wu has worked as well as dates employed the following data is not guaranteed for accuracy and should not be used for employment insurance credit eligibility or for any other purpose covered under the fair credit reporting act mijia u wu has worked at  place company novabay pharmaceuticals inc title director mijia u wus experience title director company novabay pharmaceuticals inc job details novabayr pharmaceuticals is a clinicalstage biopharmaceutical company focused on developing its proprietary and patented aganocider compounds which are novel synthetic antiinfective product candidates that are bioequivalent to the active antimicrobial molecules generated within white blood cells to treat and prevent a wide range of infections without causing bacterial resistance novabayr has internal development programs aimed at addressing dermatological hospital and respiratory infections the company has a licensing and research collaboration agreement with alcon inc for use of its aganocider compounds to treat eye ear and sinus infections as well as in contact lens care solutions novabayr has also entered into an agreement with galderma sa to develop and commercialize aganocides in acne impetigo and other dermatological indications additional professional information on mijia u wu see mijia u wus linkedin profile mijia u wus social network and potential email matches find out potential social network profiles and potential email usernamed for mijia u wu mijia u wus known social networks and potential email matches find all of mijia u wus social network profiles get full report search social networks including facebook linkedin myspace google twitter yahoo jigsaw zoominfo and more potential email matches mijia wu username matches mijiawu wumijia mijiawu wumijia mijiawu wumijia mijiawu wumijia mwu popular email services gmailcom aolcom yahoocom comcastnet hotmailcom msncom rocketmailcom attnet sbcglobalnet ymailcom facebookcom mailcom bellsouthnet livecom earthlinknet coxnet prodigynet mecom peoplepccom junocom rediffmailcom mindspringcom comcastcom charternet outlookcom all trademarks product names company names or logos on this page are the property of their respective owners related people searches m wu intelius is a leading provider of public data about people and their connections to others intelius does not provide consumer reports and is not a consumer reporting agency as defined by the fair credit reporting act fcra this site should not be used to determine an individual’s eligibility for credit insurance employment housing or any other purpose covered by the fcra for employment or tenant screening services please visit our partner talentwise about us site map about our reports blog help contact us   –  peopleconnect inc dba intelius all rights reserved privacy policy  updated terms of service  updated what is the fcra the fair credit reporting act fcra is a federal law that promotes the accuracy fairness and privacy of information in the files of consumer reporting agencies intelius does not provide consumer reports and is not a consumer reporting agency as defined by the fcra intelius reports cannot be used for background checks related to consumer credit insurance employment housing or any other purpose prohibited under the fcra you may not use any information obtained from intelius for any purpose covered by the fcra find out more about the fcra here mijia wu executive profile  biography  bloomberg july    am et capital markets company overview of shanghai rongke investment management co ltd snapshotpeople  overviewboard memberscommittees executive profile mijia wu operations director and director shanghai rongke investment management co ltdagetotal calculated compensationthis person is connected to  board members in  different organizations across  different industriessee board relationships background mr mijia wu also known as bob serves as an operations director of shanghai rongke investment management co ltd mr wu has been the managing director of china kingtonshanghai ceton investment management co ltd since june  prior to that he served as director of the ubs in hong kong branch from may  to august  he served as a vice president of bnp paribas in hong kong from september  to december  he served as a vice president assistantassistant  vice president of abn amro bank china co ltd in shanghai where he worked from october  to june  he has over  years of the highend knowledge and experience of assets inside and outside management and has a good range of interpersonal relationships in mainland china and hong kongs capital market during the abn amro bank tenure process he was a participant in the creation of abn amro banks private banking sector in china he also worked as a financial consultant and investor participate in a number of mainland private enterprises listed on overseas stock markets he managed the fund of china goldfund management co ltd as the partner he serves as a director of shanghai rongke investment management co ltd he has been a director at novabay pharmaceuticals inc since february   he has been a non executive director at china pioneer pharma holdings limited since october   he graduated from guangdong university of foreign studies with a bachelors degree in international business in june  mr wu obtained a masters degree in business administration in the manchester business school of university of the manchester in june  and an executive masters degree in business administration in cheung kong graduate school of business in october read full background corporate headquarters floor shanghai  chinaphone    fax     board members memberships operations director and directorshanghai rongke investment management co ltdpresentnonexecutive directorchina pioneer pharma holdings limitedpresentdirectornovabay pharmaceuticals inc education mba manchester business schoolbachelors degree guangdong university of foreign studiesmba cheung kong graduate school of business other affiliations manchester business schoolguangdong university of foreign studiesnovabay pharmaceuticals inccheung kong graduate school of businesschina pioneer pharma holdings limited annual compensation there is no annual compensation data available stocks options there is no stock options data available total compensation there is no total compensation data available request profile update   the information and data displayed in this profile are created and managed by sp global market intelligence a division of sp global bloombergcom does not create or control the content for inquiries please contact sp global market intelligence directly by clicking here stock quotes market data is delayed at least  minutes company lookup competitor compensationthere is no competitor compensation data available sponsored financial commentaries sponsored links browse companies a b c d e f g h i j k l m n o p q r s t u v w x y z              request profile update only a company representative may request an update for the company profile documentation will be required to contact shanghai rongke investment management co ltd please visit  company data is provided by sp global market intelligence please use this form to report any data issues information missing  please enter your information in the following fields company name your name your email address your phone number type of data overview executives key developments similar companies transactions update needed all data changes require verification from public sources please include the correct value or values and a source where we can verify cancel submit your requested update has been submitted our data partners will research the update request and update the information on this page if necessary research and followup could take several weeks if you have questions you can contact them at bwwebmasterbusinessweekcom close wu mijia  novabay pharma insider transactions  tipranks go prologin  sign up follow✓get real time transactionsinsider detailswu mijianovabay pharma nbydirector not rankedwu mijias performancewu mijia has not reported any informative transactions and therefore cannot be rankedhow are insiders ranked insider holdings  novabay pharma nbyksee the top stocks by insiders  insider rolesnovabay pharma nby directorsee the top  corporate insiders  most profitable insider tradestock novabay pharma nbytransaction type informative buydates oct    todaygain see the latest stocks traded by insiders  wu mijias trading historybased on form  follow✓get real time transactionscompany nameinsider positionholding valuelast transactionlast transaction amountlast transaction datenbynovabay pharmadirectorinformative buyoct  success rate on stock out of  profitable transactions on nbyaverage profit on stockaverage return per transaction on nby  track record showingall transactionsinformative transactionsdatetransactionamountno of sharesprice per shareprofitform  oct   informative buy k    feb   uninformative buy undisclosed   na see all insider trading from today you may also likemeet our smart portfolio see what top analysts say about your stocksget a breakdown of the different strategies based on detected insider trading activityfind the best performing analyst in each sector follow them so you never miss a recommendationrelated linkshow can i benefit from insider trading see the top  corporate insiders go to hot stocks by insiders find which stocks insiders traded today become a tipranks memberget the best investing tips  hacks straight to your emailfree membershipsubmitinsider trading daily newsletterprofessional daytrading strategy based on predictive insider transactionsannual return learn more powered by